Quick Answer
Pyxis Oncology, Inc. reported Total Revenue of $13.86 million for fiscal year 2025.
Pyxis Oncology, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $13.86M | -14.2% |
| 2024 | $16.15M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $2.82M | — | -82.5% |
| March 31, 2024 | $16.15M | — | — |
- Pyxis Oncology, Inc. showed a decrease of -14.2% in Total Revenue compared to the prior fiscal year.
- Over the 2024–2025 period, Pyxis Oncology, Inc.’s total revenue has declined by 14.2% (from $16.15 million to $13.86 million).
- The most recent figure is from Pyxis Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: